Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone palmitate injection for acute herpes zoster pain
ChiCTR2600130943Phase 4Not yet recruiting
- Sponsor
- Hangzhou Third People's Hospital
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexamethasone in herpes zoster (HZ), sponsored by Hangzhou Third People's Hospital. Primary endpoints: Pain Rating Index (PRI), Visual Analogue Scale (VAS) and 2 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2600130943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130943.